Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

Identification of prospective aging drug targets via Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 04/04/2024 - 15:03
  • Read more about Identification of prospective aging drug targets via Mendelian randomization analysis

Causal relationship between inflammatory cytokines and autoimmune thyroid disease: a bidirectional two-sample Mendelian randomization analysis

Submitted by Frida Mäkelä on Thu, 04/04/2024 - 15:01
  • Read more about Causal relationship between inflammatory cytokines and autoimmune thyroid disease: a bidirectional two-sample Mendelian randomization analysis

Potential benefits of statin therapy in reducing osteoarthritis risk: a Mendelian randomization study

Submitted by Frida Mäkelä on Thu, 04/04/2024 - 14:57
  • Read more about Potential benefits of statin therapy in reducing osteoarthritis risk: a Mendelian randomization study

Genetic insights into across pancreatitis types: the causal influence of immunoglobulin G N-glycosylation variants on disease risk

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 16:21
  • Read more about Genetic insights into across pancreatitis types: the causal influence of immunoglobulin G N-glycosylation variants on disease risk

Diet-derived circulating antioxidants, periodontitis and dental caries: A Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 16:18
  • Read more about Diet-derived circulating antioxidants, periodontitis and dental caries: A Mendelian randomization study

Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization Studies

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 10:56
  • Read more about Pharmaceutical Repurposing Strategies for Metabolic Disorders: Insights from Mendelian Randomization Studies

Multi-trait genome-wide analysis identified risk loci and candidate drugs for heart failure

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 10:50
  • Read more about Multi-trait genome-wide analysis identified risk loci and candidate drugs for heart failure

Unraveling the shared genetics of common epilepsies and general cognitive ability

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 10:45
  • Read more about Unraveling the shared genetics of common epilepsies and general cognitive ability

Cross-talk between the gut microbiota and hypothyroidism: a bidirectional two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 10:36
  • Read more about Cross-talk between the gut microbiota and hypothyroidism: a bidirectional two-sample Mendelian randomization study

Association between non-scarring alopecia and hypothyroidism: a bidirectional two-sample Mendelian randomization study

Submitted by Frida Mäkelä on Wed, 04/03/2024 - 10:33
  • Read more about Association between non-scarring alopecia and hypothyroidism: a bidirectional two-sample Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 330
  • Page 331
  • Page 332
  • Page 333
  • Current page 334
  • Page 335
  • Page 336
  • Page 337
  • Page 338
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement